Grant: Doctoral: Vanier Canada Graduate Scholarships
University of British Columbia
$150,000.00
Neuroprotective Effect of Sigma-1 Receptor and Activin A on Synaptic Function and Calcium Handling in Huntington's Disease
EF 2018-19
Résumé
Huntington's disease (HD) is a devastating inherited disease that can be detected before symptoms arise, but which is incurable. In HD patients, neurons involved in motor functions deteriorate, causing motor and cognitive problems. Neurons transmit signals in our brains, relying heavily on calcium for their function. The function impairment of the connections between neurons, known as synaptic function, as well as their ability to control calcium levels, form a common trait of many neurodegenerative disorders such as Parkinson's, Alzheimer's, and HD. One level of calcium control is at the endoplasmic reticulum (ER), a cell organelle playing a significant part in protein production. This calcium regulation is abnormal in HD, leading to a change in protein production and a decrease in synaptic function. Interestingly, activating Sigma-1 receptors (S1Rs) - proteins located on the ER that play an important role in calcium regulation and therefore protein production - has been shown to normalize this calcium handling and restore synaptic function. The purpose of this project is to determine the relationship between S1Rs, protein production, calcium handling, and synaptic function, in order to better understand the disease mechanisms of HD and other neurodegenerative diseases, and to find new potential treatments. To conduct this project, I will utilize electrophysiological, pharmacological, imaging, and behavioral techniques. As there are currently no effective treatments for HD, the results from this study may revolutionize our approach to patients with this debilitating disease.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
396708
Name
Nassrallah Wissam B
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Neuroprotective Effect of Sigma-1 Receptor and Activin A on Synaptic Function and Calcium Handling in Huntington's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Behaviour Studies; Calcium Homeostasis; Calcium Imaging; Confocal Imaging; Electrophysiology; Endoplasmic Reticulum; Fiber Photometry; Huntington'S Disease; Microscopy; Synaptic Function
Abstract
Huntington's disease (HD) is a devastating inherited disease that can be detected before symptoms arise, but which is incurable. In HD patients, neurons involved in motor functions deteriorate, causing motor and cognitive problems. Neurons transmit signals in our brains, relying heavily on calcium for their function. The function impairment of the connections between neurons, known as synaptic function, as well as their ability to control calcium levels, form a common trait of many neurodegenerative disorders such as Parkinson's, Alzheimer's, and HD. One level of calcium control is at the endoplasmic reticulum (ER), a cell organelle playing a significant part in protein production. This calcium regulation is abnormal in HD, leading to a change in protein production and a decrease in synaptic function. Interestingly, activating Sigma-1 receptors (S1Rs) - proteins located on the ER that play an important role in calcium regulation and therefore protein production - has been shown to normalize this calcium handling and restore synaptic function. The purpose of this project is to determine the relationship between S1Rs, protein production, calcium handling, and synaptic function, in order to better understand the disease mechanisms of HD and other neurodegenerative diseases, and to find new potential treatments. To conduct this project, I will utilize electrophysiological, pharmacological, imaging, and behavioral techniques. As there are currently no effective treatments for HD, the results from this study may revolutionize our approach to patients with this debilitating disease.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nassrallah, Wissam B
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~